DUBLIN, March 6, 2020 / PRNewswire / – The “catheter market by type (cardiovascular (IVUS catheter, guide catheter, balloon catheter), urology catheter (dialysis, Foley, intermittent catheter), intravenous catheter (central venous catheter)) and end user ( hospital) – Global Forecast to 2025 report “has been added to ResearchAndMarkets.com’s offer.
Global catheter market to reach $ 24.18 billion by 2025 from $ 15.94 billion in 2020, at a CAGR of 8.7%.
The growth in the market can be largely attributed to factors such as the growth of the target patient population and the increasing concentration of minimally invasive surgical procedures over conventional surgery. However, product failures and recalls, adverse tax policies and trade barriers are expected to dampen growth in this market over the forecast period. Emerging countries (such as China, India, South Korea, Brazil, and Mexico) offer significant growth opportunities to market players. This can be attributed to their low regulatory barriers, improved healthcare infrastructure, increased patient population and increased healthcare costs.
The cardiovascular catheter segment is expected to dominate the market over the forecast period.
Based on the type, the catheter market is classified into cardiovascular catheters, intravenous catheters, urological catheters, specialized catheters and neurovascular catheters. The cardiovascular catheter segment accounted for the largest share of the global catheter market in 2019. This is mainly attributed to factors such as the high incidence of cardiovascular disease, the growing geriatric population and increased awareness of early diagnosis.
The central venous catheter segment dominates and experiences the strongest growth in the intravenous catheter market.
Depending on the type of intravenous catheters, the market is segmented into central venous catheters, peripheral catheters and median peripheral catheters. Central venous catheters are estimated to account for the largest share of the intravenous catheter market. This is attributed to the broad applications of central venous catheters and the benefits of long-term access to the central venous system that they provide.
North America will dominate the market during the forecast period.
Geographically, the catheter market is segmented into North America, Europe, the Asia Pacificand the rest of the world. In 2019, North America accounted for the largest share of the catheter market. The significant share of this region can be attributed to the large number of target procedures performed in the region, the presence of a well-established health system, and investments by hospitals to modernize and expand operational capabilities.
Key topics covered:
1. Introduction
2 Research methodology
3 Summary
4 Premium Insights
4.1 Catheter market: overview
4.2 Cardiovascular market, by type, 2020 vs. 2025
4.3 Asia Pacific: Market, by end user, 2019
4.4 Market: geographic overview
5 Market overview
5.1 Introduction
5.2 Market dynamics
5.2.1 Drivers
5.2.1.1 Growth in the target patient population
5.2.1.2 Growing emphasis on minimally invasive surgical procedures
5.2.2 Constraints
5.2.2.1 Taxation and barriers to trade
5.2.2.2 Infections, complications and availability of alternatives
5.2.3 Opportunities
5.2.3.1 Emerging economies
5.2.4 Challenges
5.2.4.1 Complexities related to product development and manufacturing
5.2.4.2 Product failures and recalls
6 catheters market, by type
6.1 Introduction
6.2 Cardiovascular catheters
6.2.1 Electrophysiology catheters
6.2.1.1 Electrophysiology catheters dominate the cardiovascular catheter market
6.2.2 Angiography catheters
6.2.2.1 The Benefits of Angiography Supported the Demand for Associated Catheters
6.2.3 Balloon catheters
6.2.3.1 Demand for balloon catheters expected to swell in APAC
6.2.4 IVUS / OCT catheters
6.2.4.1 The penetration of products on the market is higher Japan compared to the United States and Europe
6.2.5 Guiding Catheters
6.2.5.1 The growing number of interventional procedures and angiography will stimulate market growth
6.3 Intravenous catheters
6.3.1 Central venous catheters
6.3.1.1 Central catheters with peripheral insertion
6.3.1.1.1 Peaks dominate the central venous catheter market
6.3.1.2 Non-tunneled central catheters
6.3.1.2.1 Non-tunneled catheters are mainly used for short-term access
6.3.1.3 Central catheters with skin tunnel
6.3.1.3.1 Skin tunnel catheters are used for long-term access and have a low risk of infection
6.3.1.4 Implantable ports
6.3.1.4.1 The great convenience and the minimized risk of infection favored the adoption of implantable ports
6.3.2 Peripheral catheters
6.3.2.1 The wide use of these devices is the main driver of market growth
6.3.3 Middle peripheral catheters
6.3.3.1 The use of peripheral middle catheters has decreased in recent years
6.4 Urological catheters
6.4.1 Urinary catheters
6.4.1.1 Indwelling catheters / Foley
6.4.1.1.1 Indwelling / Foley catheters dominate the urinary catheter market
6.4.1.2 Intermittent catheters
6.4.1.2.1 Intermittent catheters will increase at the highest CAGR over the forecast period
6.4.1.3 External catheters
6.4.1.3.1 Minimized risk of damage to the urethra and infections propelling the market for external catheters
6.4.2 Dialysis catheters
6.4.2.1 Peritoneal dialysis catheters
6.4.2.1.1 The development of new approaches for the placement of Pd catheters stimulates their adoption
6.4.2.2 Hemodialysis catheters
6.4.2.2.1 Hemodialysis catheters can be used long-term if fistulas and grafts fail
6.5 Specialized catheters
6.5.1 Pressure and hemodynamic monitoring catheters
6.5.1.1 Benefits such as continuous monitoring capabilities and a wide range of applications drive sectoral growth
6.5.2 Temperature monitoring catheters
6.5.2.1 Precision and Need for Vital Sign Monitoring Driven Demand for Temperature Monitoring Catheters
6.5.3 Intrauterine insemination catheters
6.5.3.1 IUI catheters are commonly used in infertility and for sonohysterography
6.5.4 Other specialized catheters
6.6 Neurovascular catheters
6.6.1 Growing incidence of neurological disorders stimulates the market for neurovascular catheters
7 catheters market, per end user
7.1 Introduction
7.2 Hospitals
7.2.1 High patient throughput and procedural volumes make hospitals the largest end users of catheters
7.3 Long-term care facilities
7.3.1 Growing demand for long-term care supports the growth of this end-user segment
7.4 Diagnostic imaging centers
7.4.1 The efficiency, convenience and affordability of imaging centers drive growth in this segment of end users
7.5 Other end users
8 catheters market, by region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 The United States dominates the North American market
8.2.2 Canada
8.2.2.1 The increasing prevalence of target diseases will stimulate the market Canada
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany has the largest share of the European market
8.3.2 France
8.3.2.1 Favorable government initiatives have supported the market France
8.3.3 United Kingdom
8.3.3.1 Growing prevalence of chronic diseases will boost demand for catheters in the country
8.3.4 Italy
8.3.4.1 Higher spending and investment in healthcare stimulates the Italian market
8.3.5 Spain
8.3.5.1 High cardiovascular risk and growing geriatric population will promote market growth
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Japan dominates the Asia-Pacific market for catheters
8.4.2 China
8.4.2.1 Improved healthcare infrastructure will drive market growth China
8.4.3 India
8.4.3.1 Growing availability of advanced surgical treatments and techniques will drive market growth
8.4.4 RoAPAC
8.5 grip
9 Competitive landscape
9.1 Presentation
9.2 Analysis of market ranking, 2018
9.3 Competitive scenario
9.3.1 Partnerships, agreements and collaborations (2017-2019)
9.3.2 Product launches (2017-2019)
9.3.3 Expansions (2017-2019)
9.3.4 Acquisitions (2017-2019)
9.4 Map of competitive leadership (2019)
9.4.1 Supplier inclusion criteria
9.4.2 Visionary leaders
9.4.3 Innovators
9.4.4 Dynamic differentiators
9.4.5 Emerging companies
10 company profiles
10.1 Boston Scientific Corporation
10.2 Medtronic
10.3 Becton, Dickinson and Company
10.4 Abbott
10.5 billion. Braun Melsungen AG
10.6 API of the ConvaTec group
10.7 Coloplast Group
10.8 Medical cook
10.9 Edwards Lifesciences Corporation
10.10 Johnson & Johnson Services
10.11 Merit-based medical systems
10.12 Stryker Corporation
10.13 Terumo Corporation
10.14 Teleflex Incorporated
10.15 Hollister Incorporated
10.16 AMG International GmbH
10.17 Simeks Tibbi rnler
10.18 Alvimedica
10.19 Medinol Ltd
10.20 Amsino International, Inc.
For more information on this report, visit https://www.researchandmarkets.com/r/db6qw4
Research and markets also offer personalized research services offering targeted, comprehensive and personalized research.
Media contact:
Research and markets
Laura Wood, Senior Manager
[email protected]
For E.S.T opening hours, call + 1-917-300-0470
For toll-free calls to the United States / CAN + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
American fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and markets
Related links
http://www.researchandmarkets.com